Dynamic Technology Lab Private LTD C4 Therapeutics, Inc. Transaction History

Dynamic Technology Lab Private LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$2.75 - $3.77 $1,454 - $1,994	529 Added 4.34%	12,708 $35,000
Q1 2023 May 12, 2023	BUY	$3.1 - $9.02 $37,754 - $109,854	12,179 New	12,179 $38,000
Q2 2022 Aug 12, 2022	BUY	$5.06 - $26.46 $55,877 - $292,197	11,043 Added 50.45%	32,933 $248,000
Q1 2022 May 16, 2022	BUY	$19.99 - $33.23 $198,500 - $329,973	9,930 Added 83.03%	21,890 $531,000
Q4 2021 Feb 14, 2022	BUY	$29.39 - $46.86 $351,504 - $560,445	11,960 New	11,960 $385,000

130

63.5M

670K

54.8K

Ticker CCCC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,913,800
Market Cap $170M
Description
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.